Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 20/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 20/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 16/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7018597 | 0.82 | SLC6A4 (0.37) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL7017472 | 0.82 | SLC6A4 (0.37) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL7021841 | 0.74 | SLC6A2 (0.36) | SLC6A2SLC6A4SLC6A3KCNH2OPRK1 | |
| SCHEMBL7425515 | 0.73 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL7021429 | 0.69 | SLC6A2 (0.33) | SLC6A2SLC6A4SLC6A3KCNH2OPRK1 | |
| SCHEMBL7417580 | 0.69 | DPP4 (0.30) | — | |
| SCHEMBL23665153 | 0.64 | SLC6A2 (0.58) | SLC6A2SLC6A4SLC6A3KCNH2OPRK1 | |
| SCHEMBL17043097 | 0.63 | SLC6A2 (0.60) | SLC6A2SLC6A4SLC6A3KCNH2OPRK1 | |
| SCHEMBL5987555 | 0.63 | PTGS1 (0.34) | SLC6A4KCNH2 | |
| SCHEMBL34474393 | 0.61 | SLC6A2 (0.52) | SLC6A2SLC6A4SLC6A3KCNH2OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003529546-A | — | — | 2003-10-07 | — | — | JP | claimed |
| EP-1218372-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | Boehringer Ingelheim Pharmaceuticals, Inc. (US) | 2002-07-03 | — | — | EP | claimed |
| WO-2001019816-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| EP-1218372-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | Boehringer Ingelheim Pharmaceuticals, Inc. (US) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001019816-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | disclosed |